These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6802229)

  • 1. Low doses of factor VIII for selected ankle bleeds in severe haemophilia A.
    Aronstam A; Wassef M; Hamad Z
    Br Med J (Clin Res Ed); 1982 Mar; 284(6318):790. PubMed ID: 6802229
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemarthrosis and haemophilia.
    Sterndale H
    Proc R Soc Med; 1967 Jan; 60(1):37-8. PubMed ID: 6018478
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of bleeding patterns on the response of haemophilic haemarthroses to different doses of factor VIII.
    Aronstam A; Wassef M; Hamad Z; McLellan DS
    Clin Lab Haematol; 1981; 3(2):107-12. PubMed ID: 6788433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Including the life-time cumulative number of joint bleeds in the definition of primary prophylaxis.
    den Uijl IE; Fischer K
    Thromb Haemost; 2008 May; 99(5):965; author reply 966-8. PubMed ID: 18449430
    [No Abstract]   [Full Text] [Related]  

  • 5. To bleed or not to bleed - is that a question?
    Aledort LM
    J Thromb Haemost; 2010 Jan; 8(1):81-2. PubMed ID: 19874456
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy-resistant haemarthros in a patient with factor VIII inhibitor: successful treatment with recombinant factor VIIa.
    Lenz E; Repas-Humpe M; Oldenburg J; Kreuz W; Schröter W; Eber SW
    Eur J Pediatr; 1999 Nov; 158(11):951-2. PubMed ID: 10541960
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind controlled trial of three dosage regimens in treatment of haemarthroses in haemophilia A.
    Aronstam A; Wasssef M; Choudhury DP; Turk PM; McLellan DS
    Lancet; 1980 Jan; 1(8161):169-71. PubMed ID: 6101631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of high risk knee bleeds in adolescents with severe haemophilia A.
    Aronstam A; Wassef M; Hamad Z; Aston DL
    Clin Lab Haematol; 1982; 4(1):17-21. PubMed ID: 6802553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective prophylaxis with daily recombinant factor VIIa (rFVIIa-Novoseven) in a child with high titre inhibitors and a target joint.
    Saxon BR; Shanks D; Jory CB; Williams V
    Thromb Haemost; 2001 Oct; 86(4):1126-7. PubMed ID: 11686341
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind controlled trial of two dose levels of factor VIII in the treatment of high risk haemarthroses in haemophilia A.
    Aronstam A; Wassef M; Hamad Z; Cartlidge J; McLellan D
    Clin Lab Haematol; 1983; 5(2):157-63. PubMed ID: 6411418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
    Fischer K; Valentino L; Ljung R; Blanchette V
    Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
    Lowe GD
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parachutes and prophylaxis: they both work!
    White GC
    J Thromb Haemost; 2006 Jun; 4(6):1226-7. PubMed ID: 16706964
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
    Manco-Johnson MJ; Abshire TC; Shapiro AD; Riske B; Hacker MR; Kilcoyne R; Ingram JD; Manco-Johnson ML; Funk S; Jacobson L; Valentino LA; Hoots WK; Buchanan GR; DiMichele D; Recht M; Brown D; Leissinger C; Bleak S; Cohen A; Mathew P; Matsunaga A; Medeiros D; Nugent D; Thomas GA; Thompson AA; McRedmond K; Soucie JM; Austin H; Evatt BL
    N Engl J Med; 2007 Aug; 357(6):535-44. PubMed ID: 17687129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Home-delivered ultrasound monitoring for home treatment of haemarthrosis in haemophilia A.
    Aznar JA; Pérez-Alenda S; Jaca M; García-Dasí M; Vila C; Moret A; Querol F; Bonanad S
    Haemophilia; 2015 Mar; 21(2):e147-e150. PubMed ID: 25623041
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term therapy and on-demand treatment of children and adolescents with severe haemophilia A: 12 years of experience.
    Brackmann HH; Eickhoff HJ; Oldenburg J; Hammerstein U
    Haemostasis; 1992; 22(5):251-8. PubMed ID: 1478536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
    Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
    Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosynoviorthesis in children with haemophilia.
    Pasta G; Mancuso ME; Perfetto OS; Solimeno LP
    Hamostaseologie; 2009 Oct; 29 Suppl 1():S62-4. PubMed ID: 19763357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of prophylaxis to prevent complications of hemophilia.
    Mannucci PM; Mendolicchio L; Gringeri A
    Adv Exp Med Biol; 2001; 489():59-64. PubMed ID: 11554591
    [No Abstract]   [Full Text] [Related]  

  • 20. Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort.
    Feldman BM; Rivard GE; Babyn P; Wu JKM; Steele M; Poon MC; Card RT; Israels SJ; Laferriere N; Gill K; Chan AK; Carcao M; Klaassen RJ; Cloutier S; Price VE; Dover S; Blanchette VS
    Lancet Haematol; 2018 Jun; 5(6):e252-e260. PubMed ID: 29731369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.